A

Agomab Therapeutics

35 employees

AgomAb Therapeutics is a Company is developing growth factor-mimetic agonistic monoclonal antibodies to regenerate damaged tissues.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Health Care
Therapeutics

Date founded

2017

Funding rounds raised

Total raised

$74M

from 12 investors over 12 rounds

A

Agomab Therapeutics raised $39M on July 13, 2022

Investors: Asabys Partners and Walleye Capital

A

Agomab Therapeutics raised $74M on March 10, 2021

Investors: V-Bio Ventures, Omnes, Redmile Group, Pontifax Venture Capital, AdBio partners and Andera Partners

A

Agomab Therapeutics raised $24M on April 3, 2019

Investors: AdBio partners, Omnes, V-Bio Ventures and Pontifax Venture Capital

FAQ